Below is a roundup of fitness news.
Exclusive-Novo Nordisk hires a private US company to manage certain Wegovy pen assemblies: source
Novo Nordisk has contracted private U. S. manufacturer PCI Pharma Services to handle Wegovy’s gathering and packaging, a source familiar with the matter said, as it works to ramp up production of the weight-loss drug to meet demand.
Philadelphia-based PCI, which has 15 facilities in North America, Europe and Australia, is developing self-injectable pens used to administer Wegovy, said the source, who did not want to be identified because it is confidential.
Germany launches autumn COVID vaccination campaign against high-risk groups
Germany on Monday kicked off its fall vaccination campaign to prevent respiratory infections, selling an updated COVID-19 booster vaccine only to older people or those at higher risk of illness. Germany’s public fitness body, the Robert Koch Institute, said the National Institute The Advisory Group of Independent Experts on Vaccines, known as STIKO, reiterated its advice that booster shots beyond a popular COVID vaccination cycle should only be given to certain groups that pose a threat.
Pfizer forecasts 24% COVID vaccination in U. S. This year
Pfizer expects 24% of the U. S. population, or about 82 million people, to receive the COVID-19 vaccine this year, Chief Financial Officer David Denton said at a convention Monday, reiterating the vaccine maker’s estimates this year. The administration has updated legal COVID vaccines from Pfizer and its partner BioNTech, as well as Moderna, as the country prepares to launch a vaccination campaign in the fall. A third Novavax vaccine is also being studied.
Climate substitution hampers the fight against AIDS, tuberculosis and malaria
Climate change and fighting are undermining efforts to combat three of the world’s deadliest infectious diseases, the head of the Global Fund to Fight AIDS, Tuberculosis and Malaria has warned. International disease projects have largely recovered from the hard blows caused by COVID-19. pandemic, according to the Fund’s 2023 Results Report released on Monday.
GE HealthCare Awarded $44 Million Grant to Develop AI-Assisted Ultrasound Technology
GE HealthCare Technologies Inc. Receives More Than $44 Million Grant from Bill Foundation
Novo Nordisk shares fall following media report of quality problems at U. S. plant
Novo Nordisk shares fell on Monday after currency news firm MarketWire reported that U. S. drug regulators were not in the business of the U. S. drug. The U. S. Department of Health had recently released a report detailing quality control errors at the group’s plant in Clayton, North Carolina, citing sources. Reuters was unable to authenticate the information without delay. Novo Nordisk declined to comment on the report, but said in an email that the site “works and produces for the market. “
WHO leader presses China to gain ‘full access’ to COVID origins: FT
The head of the World Health Organization has suggested Beijing provide more data on the origins of COVID-19 and is in a position to send a second team to investigate the matter, the Financial Times reported on Sunday. “We press China to grant full access and call on countries to communicate this in their bilateral meetings, to urge Beijing to cooperate,” WHO Director-General Tedros Adhanom Ghebreyesus told the newspaper.
BioNTech Secures Up to $90 Million in Funding for MPOX Vaccine Development
Germany’s BioNTech on Monday announced a partnership with a global coalition to invest up to $90 million in the progression of mpox vaccine candidates. BioNTech would initiate an early- to mid-stage trial for the BNT166 vaccine program to save mpox, a viral disease that causes rashes and can only be transmitted to humans through physical contact.
(With from agencies. )